Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome
Abstract The dopamine partial agonist aripiprazole is increasingly used to treat pathologies for which other antipsychotics are indicated because it displays fewer side effects, such as sedation and depression-like symptoms, than other dopamine receptor antagonists. Previously, we showed that aripip...
Guardado en:
Autores principales: | Alexandre Salvador, Yulia Worbe, Cécile Delorme, Giorgio Coricelli, Raphaël Gaillard, Trevor W. Robbins, Andreas Hartmann, Stefano Palminteri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84f75f853f8449c68cf25317c55a8ed1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The sooner the better: clinical and neural correlates of impulsive choice in Tourette disorder
por: Cyril Atkinson-Clement, et al.
Publicado: (2021) -
Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?
por: Yulia Worbe, et al.
Publicado: (2010) -
Neurosurgical strategies for Gilles de la Tourette’s syndrome
por: Karim Mukhida, et al.
Publicado: (2008) -
Tics, Obsesiones y Síndrome de Gilles de la Tourette: Actualización Clínica
por: Miranda,Marcelo
Publicado: (2000) -
The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
por: Tara L. Moore, et al.
Publicado: (2021)